SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-004627
Filing Date
2019-02-25
Accepted
2019-02-25 08:29:39
Documents
1
Period of Report
2019-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7369
  Complete submission text file 0000899243-19-004627.txt   8881
Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
McIntyre Gail Frances (Reporting) CIK: 0001492646 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36361 | Film No.: 19628138

Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations